The opportunities for chemistry to impact on biology and medicine are essentially limitless. Progress can only occur through collaborations with the life sciences, and to this end the Russell group has already established a number of highly successful collaborative projects in such areas as arylamine N-acetyltransferase inhibitors (for the treatment of tuberculosis and cancer) and transcriptional upregulation of utrophin (for the treatment of Duchenne Muscular Dystrophy).

In addition, we have recently instigated a number of collaborations involving more fundamental approaches to the generation of novel drug discovery paradigms, including the study of cellular signalling pathways and their application towards the development of small molecules to manipulate stem cell fate, regenerative medicines and new anti-cancer agents.

Neuromuscular Disease

Stem cell chemistry and Regenerative Medicine